Researchers Identify Genetic Subtypes Linked to Increased Risk of Ovarian Cancer
May 26, 2016
May 26, 2016
BUFFALO, N.Y., May 26 -- The Roswell Park Cancer Institute issued the following news release:
Researchers in the Center for Immunotherapy at Roswell Park Cancer Institute (RPCI) have evaluated the human leukocyte antigen (HLA), a group of genes that help regulate the body's immune system, for underlying differences in ovarian cancer patients' response to therapy. The scientists report that women with certain types of HLA may have an increased risk of ovarian cancer and may also re . . .
Researchers in the Center for Immunotherapy at Roswell Park Cancer Institute (RPCI) have evaluated the human leukocyte antigen (HLA), a group of genes that help regulate the body's immune system, for underlying differences in ovarian cancer patients' response to therapy. The scientists report that women with certain types of HLA may have an increased risk of ovarian cancer and may also re . . .